Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-18 Purchase | 2025-08-20 4:02 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 75,000 | $0.7787 | $58,402 | 75,000 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 4:12 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 611 | $0.6404 | $391 | 89,198 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 4:09 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 2,382 | $0.6404 | $1,525 | 212,888 (Direct) | View |
| 2025-07-07 Sale | 2025-07-08 4:37 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 2,011 | $0.4501 | $905 | 86,809 (Direct) | View |
| 2025-06-30 Sale | 2025-07-01 4:22 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 1,532 | $0.43 | $659 | 88,820 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:25 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 550 | $1.1502 | $633 | 87,352 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:23 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 1,326 | $1.1502 | $1,525 | 579,388 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:20 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 2,159 | $1.1502 | $2,483 | 170,270 (Direct) | View |
| 2025-01-06 Sale | 2025-01-08 4:10 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly Interim CFO | 2,221 | $1.8 | $3,998 | 87,902 (Direct) | View |
| 2024-12-30 Sale | 2025-01-02 4:46 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly Interim CFO | 1,426 | $1.5802 | $2,253 | 90,123 (Direct) | View |
| 2024-12-30 Sale | 2025-01-02 4:43 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 10,796 | $1.5802 | $17,060 | 580,714 (Direct) | View |
| 2024-12-02 Purchase | 2024-12-04 4:17 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 30,000 | $1.5468 | $46,404 | 33,000 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 5:10 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 564 | $2.58 | $1,455 | 91,549 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 5:09 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia CHIEF MEDICAL OFFICER | 1,365 | $2.58 | $3,522 | 325,711 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 5:06 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 1,937 | $2.58 | $4,997 | 591,510 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-12 Option Award | 2025-08-13 4:47 pm | N/A 2035-08-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Curran Daniel J. Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:29 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:19 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:16 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:14 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 4:45 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 3,000 | $0 | 90,352 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 4:41 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 42,000 | $0 | 212,270 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:32 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:30 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:29 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director 10% Owner | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:27 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Takimoto Chris H Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:24 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Klencke Barbara Director | 40,400 | $0 | 40,400 (Direct) | View |
Ownership | 2025-01-23 6:22 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Klencke Barbara Director | 0 | $0 | 120,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:19 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:14 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 112,000 | $0 | 112,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:11 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:09 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:07 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 478,000 | $0 | 478,000 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 4:15 pm | N/A 2031-12-01 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly Interim CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 4:13 pm | N/A 2031-12-01 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-19 4:05 pm | N/A 2034-11-17 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 5:08 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S CHIEF FINANCIAL OFFICER | 761 | $2.58 | 121,516 (Direct) | View |